| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044229A1 Chemokine receptor binding heterocyclic compounds |
| 06/21/2001 | WO2001044228A2 Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044218A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044197A2 2-phenyl-quinoline derivatives and their use as contracting agent for smooth muscles |
| 06/21/2001 | WO2001044192A1 Cyclic quaternary ammonium compounds |
| 06/21/2001 | WO2001044189A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044188A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001044167A1 Quaternary ammonium compounds and their use as anti-tussive agents |
| 06/21/2001 | WO2001044164A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043761A2 Methods for treating and preventing damage to mucosal tissue |
| 06/21/2001 | WO2001043747A1 Matrix tablet for prolonged release of trimetazidine after oral administration |
| 06/21/2001 | WO2001043734A2 Transdermal administration of phenylpropanolamine |
| 06/21/2001 | WO2001043726A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | WO2001043692A2 SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/21/2001 | WO2001043540A2 Methods for producing transgenic animals |
| 06/21/2001 | WO2001013892A3 Large porous particles by spray-drying |
| 06/21/2001 | CA2395486A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | CA2395289A1 Transdermal administration of phenylpropanolamine |
| 06/21/2001 | CA2395119A1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | CA2394077A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2390674A1 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/20/2001 | EP1108424A1 Matrix tablet for sustained release of trimetazidine after oral administration |
| 06/20/2001 | EP1108047A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108033A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |
| 06/20/2001 | EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107973A1 Novel compounds |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107959A2 Quinazoline derivatives as medicaments |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107794A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107778A1 Treatment of disease states |
| 06/20/2001 | EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 06/20/2001 | EP1107774A1 Ramp2a: receptor activity modifying protein-2a |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107747A1 Therapies for treating pulmonary diseases |
| 06/20/2001 | EP1107743A1 Stable spray-dried protein formulations |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107740A1 Timed release tablet comprising naproxen and pseudoephedrine |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107733A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107732A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107722A2 A method for the treatment of staphylococcal disease |
| 06/20/2001 | EP0984961B1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 06/20/2001 | EP0808303B1 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |
| 06/20/2001 | CN1299680A Dressing for treating infantile bronchitis and pulmonitis and its preparation |
| 06/20/2001 | CN1299665A Shuangqi granule for protecting lungs and eliminating allergy |
| 06/20/2001 | CN1299656A Asthma treating medicine and its production process |
| 06/20/2001 | CN1299651A Dressing for treating infantile bronchitis and pulmonitis and its preparation |
| 06/20/2001 | CN1067275C Snow ganoderma lucidum oral liquid |
| 06/20/2001 | CN1067274C Snow ganoderma lucidum solid medicament |
| 06/20/2001 | CN1067264C Medicinal patch for treatment of cough and asthma |
| 06/20/2001 | CN1067245C Application of N-aceto-D-aminoglucosein medicinal preparation for cuing respiratory tract diseases |
| 06/19/2001 | US6248785 IL-8 receptor antagonists |
| 06/19/2001 | US6248767 Formulation of sulfonamides for treatment of endothelin-mediated disorders |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248746 Phosphodiesterase (pde-iv) inhibitor for treatment of asthma, allergies, atopic diseases and rhinitis |
| 06/19/2001 | US6248740 Condensed pyridazine derivatives, their production and use |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248358 Bioadhesive progressive hydration tablets and methods of making and using the same |
| 06/19/2001 | US6248308 Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| 06/19/2001 | US6248305 Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use |
| 06/19/2001 | CA2218616C Nitrosylated neuropeptides |
| 06/14/2001 | WO2001042457A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses |
| 06/14/2001 | WO2001042450A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/14/2001 | WO2001042252A1 New aminopropylphosphinic acids |